Shibutani Y
No ORCID on file
· 5 papers in corpus
· active 1997-1999
Study types
- article 5
Condition tags
- endometriosis 3
Top journals
Frequent coauthors
- Yasunori Shibutani 5
- Yukio Katsuki 5
- Katsuki Y 5
- Aoki D 3
- Shunsuke Nozawa 3
- Nozawa S 3
- Daisuke Aoki 3
- Takano Y 2
- Udagawa Y 2
- Yuko Takano 2
article
1999
Orally administered dienogest (17alpha-cyanomethyl-17beta-hydroxy-estra-4,9-diene-3-one) is efficacious against human hormone-dependent cancer xenografts in severely immunodeficient mice and in rats with experimental endometriosis, but its …
article
1999
We investigated the effect of dienogest on bleeding time, coagulation, fibrinolysis, and platelet aggregation in female rats compared with that of medroxyprogesterone acetate (MPA) and danazol, in order to elucidate the reason for relativel…
article
1998
OBJECTIVE: Dienogest, a synthetic steroid with progestational activity, is used as a component of oral contraceptives and is currently being evaluated clinically for the treatment of endometriosis. The present study was conducted to confirm…
article
1997
Dienogest is an orally active synthetic steroid that is used for contraception and is currently being studied for the possible treatment of endometriosis. Earlier we demonstrated that dienogest had therapeutic effects on experimental endome…
article
1997
BACKGROUND: Dienogest is a synthetic progestational steroid that is used for contraception. It is being studied for the treatment of endometriosis, but its anticancer activity remains unknown. The authors investigated the anticancer effect …